CADL vs JNJ · $592.0M cap vs P/E 17, rev $49.37B
Candel Therapeutics Inc (CADL) versus Johnson & Johnson (JNJ) — a side-by-side from cached financials, not a winner call.
Candel Therapeutics Inc (CADL) is a biotechnology company listed on NASDAQ.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
CADL does not have a complete income-statement cache yet.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
CADL currently screens at market cap $592.0M. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Not investment advice. Open the CADL and JNJ stock pages for the full models.
Not investment advice.